+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Reproductive responses of dairy cows with ovarian cysts to simultaneous human chorionic gonadotropin or gonadotropin-releasing hormone and cloprostenol compared to gonadotropin-releasing hormone alone treatment

Reproductive responses of dairy cows with ovarian cysts to simultaneous human chorionic gonadotropin or gonadotropin-releasing hormone and cloprostenol compared to gonadotropin-releasing hormone alone treatment

Veterinary World 8(5): 640-644

Bovine ovarian cysts are a common cause of economic loss in modern dairy herds. The objective of the present study was to evaluate the reproductive responses to three protocols using hCG, GnRH and cloprostenol when the definite diagnosis of the type of ovarian cyst is/is not possible in dairy cows. A total of 144 lactating dairy cows with ovarian cysts were divided into three groups. At diagnosis (Day 0), cows in Group 1 (the conventional method, n=47) were injected with 0.02 mg of a GnRH analogue i.m. (Buserelin); cows in Group 2 (n=47) were intramuscularly treated with 0.02 mg Buserelin plus 500 µg cloprostenol; and cows in Group 3 (n=50) were intramuscularly treated with 1500 IU hCG plus 500 µg cloprostenol. All cows received 500 µg cloprostenol intramuscularly on Day 10. No statistically significant differences were found in the recovery time, interval to conception, conception rate at first AI, and pregnancy rates by Days 70 and 100 after treatment among the three groups. Simultaneous treatment of ovarian cysts with hCG or GnRH and cloprostenol appeared to have no advantage over the conventional method, GnRH alone, in dairy cows. Furthermore, hCG and GnRH have an equal therapeutic effect in cows with ovarian cysts.

(PDF emailed within 0-6 h: $19.90)

Accession: 058748526

Download citation: RISBibTeXText

PMID: 27047149

DOI: 10.14202/vetworld.2015.640-644

Related references

Hormone response of dairy cows with ovarian cysts after treatment with human chorionic gonadotropin or gonadotropin releasing hormone. Theriogenology 6(4): 413-425, 1976

Effect of gonadotropin-releasing hormone and human chorionic gonadotropin on cows with ovarian follicular cysts. American Journal of Veterinary Research 37(2): 153-157, 1976

Ovarian cysts in dairy cattle some aspects of diagnosis treatment with gonadotropin releasing hormone and human chorionic gonadotropin and subsequent milk progesterone values. Nordisk Veterinaermedicin 36(1-2): 26-31, 1984

Effects of a systematic application of human chorionic gonadotropin, gonadotropin-releasing hormone analog and bovine anterior pituitary gonadotropin in cows with cystic ovarian disease. Theriogenology 11(5): 385-397, 1979

Gonadotropin releasing hormone stimulation of gonadotropin release from the pituitary regulation of cell responses and gonadotropin releasing hormone receptors by gonadotropin releasing hormone receptor micro aggregation. Journal of Cellular Biochemistry Supplement (8 PART A): 233, 1984

Influence of continuous gonadotropin releasing hormone agonist treatment on luteinizing hormone and testosterone secretion the response to gonadotropin releasing hormone and the testicular response to human chorionic gonadotropin in male rhesus monkeys. Journal of Clinical Endocrinology & Metabolism 58(2): 262-267, 1984

Ovarian responses of seasonally anestrous ewes administered progesterone, PMS, HCG, and(or) GnRH Pregnant mare serum gonadotropin, human chorionic gonadotropin, gonadotropin releasing hormone. Theriogenology 19(3): 449-463, 1983

Ovarian cysts in dairy cattle observations of symptoms and milk progesterone values therapy with gonadotropin releasing hormone and a combination of gonadotropin releasing hormone and prostaglandin. Nordisk Veterinaermedicin 36(11): 361-366, 1984

The effect of human chorionic gonadotropin and gonadotropin releasing hormone on the ovaries of cows with follicular cysts. Zuchthygiene (Berlin) 15(3): 126-131, 1980

Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles. Journal of Obstetrics and Gynaecology Research 42(9): 1146-1151, 2017

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertility and Sterility 91(2): 365-371, 2008

Response of human chorionic gonadotropin to 6 d tryptophan gonadotropin releasing hormone and gonadotropin releasing hormone stimulation in the culture media of normal human placenta of different gestational ages. Journal of Catholic Medical College 43(1): 219-226, 1990

The use of equine chorionic gonadotropin in the treatment of anestrous dairy cows in gonadotropin-releasing hormone/progesterone protocols of 6 or 7 days. Journal of Dairy Science 96(1): 122-131, 2013

Administration of human chorionic gonadotropin to suckled beef cows before ovulation synchronization and fixed-time insemination: replacement of gonadotropin-releasing hormone with human chorionic gonadotropin. Journal of Animal Science 89(10): 3030-3039, 2012

Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles. Fertility and Sterility 62(1): 35-41, 1994